Shanghai, China

Xiumei Cai

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 3.5

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2019-2024

Loading Chart...
Loading Chart...
6 patents (USPTO):

Title: Innovations and Contributions of Inventor Xiumei Cai

Introduction

Xiumei Cai is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of innovative therapies for various diseases. With a total of six patents to his name, Cai's work focuses on immunologic effector cells and their applications in treating tumors and autoimmune diseases.

Latest Patents

Cai's latest patents include groundbreaking inventions such as the immunologic effector cell targeting CLD18A2. This invention discloses a chimeric antigen receptor (CAR) that specifically recognizes CLD18A2, which can be utilized to treat tumors like pancreatic and stomach cancer. Another notable patent involves a polypeptide and an antibody bound to the polypeptide, designed to treat autoimmune diseases by inhibiting the activity induced by pro brain-derived neurotrophic factor (pro-BDNF). This innovation has the potential to address conditions such as rheumatoid arthritis, psoriasis, systemic lupus erythematosus, and multiple sclerosis.

Career Highlights

Throughout his career, Xiumei Cai has worked with several notable companies, including Crage Medical Co., Limited and Shanghai Yile Biotechnology Co., Ltd. His expertise in biotechnology and innovative therapies has positioned him as a key figure in the industry.

Collaborations

Cai has collaborated with various professionals in his field, including Huamao Wang and Bo Song. These collaborations have further enhanced his research and development efforts, leading to significant advancements in biotechnology.

Conclusion

Xiumei Cai's contributions to the field of biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for innovative treatments for serious health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…